Allen Mooney & Barnes Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,056
Closed -$529K 160
2025
Q2
$529K Buy
6,056
+115
+2% +$9.01K 0.09% 102
2025
Q1
$406K Sell
5,941
-191
-3% -$15.6K 0.07% 111
2024
Q4
$477K Buy
+6,132
New +$454K 0.08% 106

Other funds holding DXCM

Allen Mooney & Barnes Investment Advisors's DXCM Position: Q3 2025 in Review

Allen Mooney & Barnes Investment Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 6,056 shares — an estimated $529K sold.

Allen Mooney & Barnes Investment Advisors first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $529K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Allen Mooney & Barnes Investment Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Allen Mooney & Barnes Investment Advisors sold 6,056 DexCom shares in Q3 2025, an estimated $529K.
  • Allen Mooney & Barnes Investment Advisors first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Allen Mooney & Barnes Investment Advisors's DexCom position peaked at $529K in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q3 2025, filed 15 Oct 2025.